The Patent Finder

Bikam Pharmaceuticals Inc.

Also on record
Records under this name other than patents Bikam Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 7 of 7 · Back to Bikam Pharmaceuticals Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,353,063Opsin-binding ligands, compositions and methods of use
Lapsed on the fee record
Ended May 31, 2024 · USPTO record
Lapsed on the fee recordEnded May 31, 2024USPTO record
US 9,133,082Opsin-binding ligands, compositions and methods of use
Lapsed on the fee record
Ended Sep 15, 2023 · USPTO record
Lapsed on the fee recordEnded Sep 15, 2023USPTO record
US 10,040,749Opsin-binding ligands, compositions and methods of use
Lapsed on the fee record
Ended Aug 7, 2022 · USPTO record
Lapsed on the fee recordEnded Aug 7, 2022USPTO record
US 9,757,370Opsin-Binding Ligands, Compositions and Methods of Use
Lapsed on the fee record
Ended Sep 12, 2021 · Medium confidence
Lapsed on the fee recordEnded Sep 12, 2021Medium confidence
US 9,562,022Opsin-Binding Ligands, Compositions and Methods of Use
Lapsed on the fee record
Ended Feb 7, 2021 · High confidence
Lapsed on the fee recordEnded Feb 7, 2021High confidence
US 9,499,464Opsin-binding ligands, compositions and methods of use
Lapsed on the fee record
Ended Nov 22, 2020 · USPTO record
Lapsed on the fee recordEnded Nov 22, 2020USPTO record
US 9,457,004Opsin-binding ligands, compositions and methods of use
Lapsed on the fee record
Ended Oct 4, 2020 · USPTO record
Lapsed on the fee recordEnded Oct 4, 2020USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited